Competition Law and Serial Acquisition Antitrust Risks

1. Introduction

A serial acquisition strategy occurs when a company, investment fund, private-equity sponsor, or other business repeatedly acquires smaller companies in the same or related markets. It is often called a roll-up strategy.

Serial acquisitions are not automatically unlawful. Businesses can legitimately use repeated acquisitions to expand geographically, gain technology, obtain complementary products, or achieve economies of scale. The competition-law problem arises when the cumulative effect of successive transactions substantially reduces competition, creates or strengthens market power, eliminates important rivals, or facilitates exclusionary conduct.

This issue has become particularly important in the United States because individual acquisitions may sometimes be too small to trigger pre-merger reporting requirements, while dozens of such transactions together may significantly change the structure of a market. In 2024, the FTC and DOJ specifically sought information about serial acquisitions and roll-up strategies, noting that a series of relatively small transactions can produce substantial consolidation even where individual transactions escape advance review.

The principal U.S. legal provisions relevant to these strategies include:

• Section 7 of the Clayton Act — acquisitions whose effect may be substantially to lessen competition or tend to create a monopoly.
• Section 1 of the Sherman Act — anticompetitive agreements associated with an acquisition strategy.
• Section 2 of the Sherman Act — monopolization and attempted monopolization.
• Section 5 of the FTC Act — unfair methods of competition.

The central principle is that competition authorities may examine not merely the size of one transaction, but also the economic environment created by a continuing acquisition program.

2. What Is a Serial Acquisition?

Consider a market containing 50 independent service providers.

A large company purchases five firms in the first year, six in the second, another eight in the third, and continues acquiring competitors.

No individual transaction necessarily looks transformative. But after several years, the acquiring company may control a substantial proportion of:

• customers,
• facilities,
• employees,
• intellectual property,
• distribution,
• data,
• suppliers, or
• local capacity.

Competition law therefore asks whether the transactions collectively contribute to a market structure in which effective competition is materially reduced.

The FTC's actions concerning veterinary services illustrate the concern. In its proceedings involving JAB Consumer Partners, the FTC imposed divestitures as well as prior-notice and prior-approval obligations covering certain future veterinary-clinic acquisitions.

3. Why Serial Acquisitions Create Antitrust Risk

A. Gradual increase in concentration

One of the most obvious risks is incremental concentration.

Instead of acquiring one major competitor, an enterprise may acquire many smaller competitors over several years.

The result can nevertheless be:

Independent firms → repeated acquisitions → fewer competitors → greater concentration → increased market power

The competition authority may therefore consider the acquiring firm's existing portfolio when evaluating another acquisition.

B. Elimination of local competitors

Serial acquisitions can be particularly important where competition occurs locally.

Examples include:

• medical practices,
• veterinary clinics,
• dental practices,
• pharmacies,
• repair businesses,
• waste services,
• funeral services, and
• specialized professional services.

A national market may contain hundreds of firms while individual cities have only a few meaningful alternatives.

The FTC has specifically observed that serial acquisitions can raise particular concerns in sectors where competition is primarily local.

4. Transactions Below Reporting Thresholds

A major enforcement concern involves acquisitions that individually fall below mandatory notification thresholds.

Suppose a hypothetical reporting threshold were $150 million.

A company might make:

• Acquisition A — $20 million
• Acquisition B — $30 million
• Acquisition C — $25 million
• Acquisition D — $40 million
• Acquisition E — $35 million

Each transaction could potentially fall below the applicable threshold even though the combined acquisition program materially changes the market.

Whether reporting is actually required depends on the applicable statutory rules and current thresholds, but non-reportability does not itself make an acquisition lawful under substantive antitrust law.

The FTC and DOJ have highlighted precisely this enforcement concern in discussing serial acquisitions.

5. Market Definition and Serial Acquisitions

Authorities normally determine the relevant:

Product market

and

Geographic market.

For example, acquiring ten veterinary practices nationally may initially appear insignificant.

But if six of those clinics operate in one metropolitan area, the competitive consequences can be much greater in the properly defined local market.

The FTC's JAB veterinary proceedings demonstrate this approach. The Commission identified specific geographic markets—including areas around Austin, San Francisco, Oakland/Berkeley/Concord, Richmond, Denver, and Washington, D.C.—rather than treating veterinary services as one undifferentiated nationwide market.

6. Horizontal Serial Acquisitions

The clearest antitrust concerns generally arise when the purchaser repeatedly buys direct competitors.

Suppose:

Company A buys Competitor B.

It subsequently buys C, D, E and F.

Each acquisition eliminates another independent competitive decision-maker.

Potential effects include:

• higher concentration,
• reduced price competition,
• reduced customer choice,
• lower incentives to improve quality,
• diminished innovation, and
• greater bargaining power over customers.

The analysis remains transaction- and market-specific; repeated acquisitions do not establish illegality by themselves.

7. Vertical Serial Acquisitions

Serial acquisitions can also involve businesses at different levels of a supply chain.

For example:

Manufacturer → distributor → logistics provider → important input supplier

The issue may become foreclosure.

A vertically integrated company might have the ability and incentive to restrict rivals' access to important:

• inputs,
• distribution channels,
• technology,
• data,
• infrastructure, or
• customers.

Vertical acquisitions therefore require analysis beyond simple market-share addition.

8. Potential Competition

Competition law can also protect competition that has not yet fully developed.

A dominant company could repeatedly purchase emerging businesses that might otherwise grow into meaningful competitors.

Authorities may therefore examine:

• the target's technology,
• expansion plans,
• customer growth,
• internal forecasts,
• product-development plans, and
• likelihood of entering adjacent markets.

This is particularly significant in technology and innovation-intensive industries.

9. Innovation Competition

Serial acquisition strategies can affect innovation even where immediate price effects are difficult to establish.

Suppose ten independent technology firms are developing competing products.

A major incumbent purchases several of them.

The concern may be that independent experimentation and innovation have been reduced.

The FTC's Illumina/GRAIL proceedings demonstrate the broader importance of innovation theories in merger law: the FTC challenged the transaction partly on the theory that control over an important sequencing input could diminish innovation and competition in multi-cancer early-detection testing. Although not itself a classic serial-acquisition case, it is important for understanding how acquisition law can address future and innovation competition.

10. Private Equity Roll-Ups

Private-equity structures receive particular attention because a common business model involves:

Platform acquisition + numerous add-on acquisitions

For example:

PE Fund
↓
Platform Company
↓
Target 1 + Target 2 + Target 3 + Target 4 + Target 5

Again, the structure itself is lawful.

The relevant question is whether particular acquisitions or related conduct substantially lessen competition or contribute to unlawful monopolization.

The FTC's litigation concerning U.S. Anesthesia Partners (USAP) and Welsh Carson is especially important in this area. The FTC alleged that USAP and Welsh Carson pursued a multi-year strategy involving acquisitions of anesthesia practices in Texas, alongside other allegedly restrictive arrangements. These were FTC allegations rather than automatic legal conclusions about private-equity roll-ups generally.

11. Labour-Market Risks

Serial acquisitions can also affect workers.

Suppose many independent medical practices compete for anesthesiologists.

If those practices are progressively consolidated under one owner, the number of employers competing for the same workers may decline.

Competition authorities can therefore examine effects on:

• wages,
• salaries,
• employment opportunities,
• mobility,
• working conditions, and
• bargaining power.

The relevant labor market can differ from the downstream market in which services are sold.

12. Internal Documents and Acquisition Strategy

Internal business documents can become important evidence.

Authorities may examine:

• board presentations,
• investment committee papers,
• acquisition pipelines,
• strategic plans,
• emails,
• market studies,
• pricing forecasts, and
• competitive analyses.

For example, statements describing plans to consolidate fragmented competitors can help authorities understand the commercial strategy, although such language alone does not establish an antitrust violation.

Economic evidence about actual competitive effects remains crucial.

13. Prior Notice and Prior Approval Remedies

A significant consequence of serial-acquisition enforcement is that authorities may seek restrictions concerning future transactions.

The JAB veterinary matters are important examples.

In the SAGE transaction, the FTC required JAB to obtain prior approval for specified future acquisitions near JAB-owned clinics in California and Texas and imposed broader prior-notice obligations for certain transactions that otherwise might not require HSR notification.

In the subsequent Ethos matter, the FTC again required divestitures and imposed prior-approval and prior-notice obligations covering specified veterinary acquisitions.

Thus, enforcement against one acquisition can influence how a company's future acquisition program is supervised.

14. Retrospective Challenges

Another important principle is that closing a transaction does not necessarily eliminate substantive antitrust exposure.

Depending on the statute and circumstances, competition authorities may challenge consummated acquisitions.

Consequently, businesses conducting repeated smaller transactions cannot safely assume:

small transaction + no pre-merger notification = no antitrust risk.

The substantive competition analysis remains distinct from the procedural question of whether advance notification was required.

Important Case Laws and Enforcement Proceedings

1. Brown Shoe Co. v. United States (1962)

Court: U.S. Supreme Court

Brown Shoe remains one of the foundational Section 7 merger cases.

Brown Shoe acquired Kinney, another shoe company. The government challenged the transaction under Section 7 of the Clayton Act.

Principle

The Supreme Court emphasized that Section 7 is designed to stop anticompetitive concentration before it develops fully.

The decision demonstrates the preventive character of merger control.

Importance for serial acquisitions

Serial-acquisition enforcement follows a similar preventive logic.

Authorities need not necessarily wait until a company achieves an absolute monopoly before examining whether additional acquisitions threaten competition.

2. United States v. Philadelphia National Bank (1963)

Court: U.S. Supreme Court

The case involved a merger between major banks in Philadelphia.

The Supreme Court treated substantial increases in concentration as highly significant under Section 7.

Principle

Market concentration and market shares can provide powerful evidence about the likely competitive consequences of a transaction.

Serial-acquisition relevance

A series of acquisitions may gradually increase the purchaser's market share.

Therefore, transaction number ten may present materially greater competition concerns than transaction number one because the acquiring firm's existing position has changed.

3. FTC v. Procter & Gamble Co. (1967)

Court: U.S. Supreme Court

Procter & Gamble acquired Clorox, a major producer of household liquid bleach.

The Supreme Court upheld the challenge.

One important concern involved the loss of potential competition associated with a powerful firm acquiring an established participant rather than entering independently.

Serial-acquisition relevance

The case helps explain why authorities may examine whether an acquirer could have expanded independently rather than continually purchasing competitors.

It also demonstrates that merger analysis extends beyond simple arithmetic addition of current market shares.

4. United States v. Von's Grocery Co. (1966)

Court: U.S. Supreme Court

This case concerned consolidation in grocery retailing.

The Court considered the decline in the number of independent grocery businesses and the broader movement toward concentration.

Principle

Section 7 historically has been applied preventively where market structure shows significant consolidation.

Serial-acquisition relevance

The case is particularly relevant conceptually because repeated acquisitions can gradually eliminate independent businesses even though no single acquisition initially appears decisive.

5. United States v. General Dynamics Corp. (1974)

Court: U.S. Supreme Court

General Dynamics demonstrates an important limitation on purely structural analysis.

Although market-share statistics matter, the Supreme Court examined the commercial realities of the market and concluded that historical statistics did not adequately represent the acquired company's future competitive significance.

Principle

Competition analysis requires economic reality rather than mechanical reliance on concentration figures.

Serial-acquisition relevance

Authorities examining roll-ups should therefore consider not only the number of businesses acquired but also:

• remaining competitive capacity,
• future output,
• entry conditions,
• customer alternatives, and
• actual competitive significance.

6. FTC v. H.J. Heinz Co. (2001)

Court: U.S. Court of Appeals for the D.C. Circuit

The case concerned the proposed combination of Heinz and Beech-Nut in the baby-food market.

The court emphasized the competitive concerns arising from significant concentration and rejected the defendants' efficiencies showing as insufficient in the circumstances.

Principle

Highly concentrated markets can make additional consolidation particularly problematic.

Serial-acquisition relevance

A roll-up strategy may progressively transform a fragmented market into a concentrated one. Later acquisitions can therefore receive considerably greater scrutiny than earlier transactions.

7. FTC v. Staples, Inc. (1997)

Court: U.S. District Court for the District of Columbia

The FTC challenged Staples' proposed acquisition of Office Depot.

Evidence concerning pricing behavior showed that competition between office-superstore chains affected prices.

Principle

Actual competitive interaction between firms can be highly important in merger analysis.

Serial-acquisition relevance

When a serial acquirer repeatedly purchases its closest local competitors, evidence showing that those firms previously constrained its prices or service levels can strongly influence the competitive analysis.

8. FTC v. Penn State Hershey Medical Center (2016)

Court: U.S. Court of Appeals for the Third Circuit

The case concerned a proposed hospital merger.

The appellate court disagreed with important aspects of the district court's geographic-market analysis and supported the FTC's attempt to block the transaction.

Principle

Correct market definition is critical in healthcare consolidation.

Serial-acquisition relevance

Healthcare roll-ups frequently occur in geographically limited markets. A collection of acquisitions that appears modest nationally can create substantial concentration within a particular city or region.

9. In re JAB Consumer Partners / SAGE Veterinary Partners (2022)

This FTC proceeding is particularly relevant to modern serial-acquisition analysis.

JAB controlled veterinary-clinic businesses and proposed acquiring SAGE Veterinary Partners.

The FTC alleged competitive harm in several local specialty and emergency veterinary markets and required clinic divestitures.

More importantly for roll-up analysis, the order imposed prior-approval and prior-notice requirements concerning future acquisitions.

Significance

The proceeding demonstrates that regulators can respond to repeated acquisitions not merely by modifying one transaction but by increasing scrutiny of subsequent transactions.

10. In re JAB Consumer Partners / Ethos Veterinary Health (2022)

Soon after the SAGE matter, JAB proposed acquiring Ethos Veterinary Health.

The FTC again identified competition concerns in local specialty and emergency veterinary markets.

It required divestitures in areas including Richmond, Washington, D.C., Denver and San Francisco and imposed additional restrictions regarding future acquisitions.

Significance

Taken together, the SAGE and Ethos proceedings are especially useful examples of regulators examining acquisitions against the background of an ongoing consolidation strategy.

11. FTC v. U.S. Anesthesia Partners & Welsh Carson

This is one of the clearest modern proceedings concerning an alleged roll-up strategy.

In 2023, the FTC sued U.S. Anesthesia Partners and Welsh Carson.

According to the FTC's complaint, USAP systematically acquired anesthesia practices across Texas and combined those acquisitions with other allegedly restrictive arrangements. The defendants contested aspects of the government's case, so the allegations should be distinguished from adjudicated findings.

In January 2025, the FTC announced a separate settlement with Welsh Carson concerning its relationship with USAP and specified future investments and acquisitions.

Significance

The matter demonstrates that authorities can investigate the overall course of conduct surrounding a series of acquisitions, rather than treating every transaction as economically isolated.

15. Main Factors Used to Assess Serial Acquisition Risk

Competition authorities generally examine several interconnected factors.

No single factor automatically determines legality.

16. Efficiencies and Legitimate Reasons for Serial Acquisitions

Serial acquisitions can generate genuine economic benefits.

Possible efficiencies include:

• centralized administration,
• improved technology,
• better procurement,
• lower operating costs,
• improved logistics,
• wider geographic coverage,
• stronger investment capacity,
• better utilization of equipment, and
• integration of complementary services.

However, competition authorities generally distinguish transaction-specific efficiencies from savings that could reasonably be achieved without the competitively problematic acquisition.

Therefore, claiming that a roll-up creates economies of scale does not automatically answer the competition question.

17. Serial Acquisitions vs. Ordinary Expansion

The fundamental distinction can be summarized as follows:

Ordinary expansion

Acquisitions → efficiencies → stronger competition → consumer benefits.

Potentially problematic roll-up

Repeated competitor acquisitions → fewer independent rivals → higher concentration → greater market power → possible price, quality, innovation, or labor-market harm.

Competition law focuses primarily on the competitive consequences, rather than simply the fact that the company used acquisitions to grow.

18. Remedies

Where authorities establish competition concerns, remedies can include:

Structural remedies

• divestiture of acquired businesses,
• sale of facilities,
• divestiture of intellectual property,
• separation of business operations.

Behavioral or procedural remedies

• prior notice of future acquisitions,
• prior approval requirements,
• restrictions on particular agreements,
• information-access obligations,
• compliance monitoring.

The JAB veterinary orders demonstrate how prior-notice and prior-approval requirements can be used where regulators are concerned about continued acquisition activity.

19. Overall Legal Position

The key point is that serial acquisition is a business strategy, not an antitrust violation by definition.

The antitrust risk increases when repeated acquisitions progressively eliminate meaningful competitors or otherwise create conditions in which the acquiring firm can exercise greater market power.

Modern enforcement therefore increasingly considers the sequence:

Fragmented market
→ platform acquisition
→ repeated add-on acquisitions
→ declining independent competition
→ increasing concentration
→ potential market power
→ antitrust scrutiny

The classic Supreme Court authorities—Brown Shoe, Philadelphia National Bank, Von's Grocery, Procter & Gamble, and General Dynamics—provide much of the structural and economic foundation for merger analysis. More recent proceedings such as JAB/SAGE, JAB/Ethos, and USAP/Welsh Carson demonstrate how those principles can become relevant to modern private-equity and corporate roll-up strategies.

Accordingly, the central competition-law question is not simply “Was each individual acquisition small?” It is whether an acquisition, viewed in its actual market context and where legally relevant against the background of previous transactions and related conduct, may substantially lessen competition, tend toward monopoly, or form part of independently unlawful exclusionary conduct.